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Abstract
Telomeres protect linear chromosome ends from being recognized and processed as double-strand
breaks by DNA repair activities. This protective function of telomeres is essential for chromosome
stability. Until recently, telomeres have been considered to be transcriptionally silent. This notion
was overturned in a series of recent papers that describe the existence of telomeric repeat-
containing RNAs (TERRAs) in vertebrates and yeast. Here, we summarize recent developments in
this field of telomere research, in particular the possible mechanisms that control TERRA expression.
Introduction and context
Telomerase is a specialized ribonucleoprotein complex
that maintains the integrity and stability of eukaryotic
chromosome ends [1-3]. Since conventional DNA
replication enzymes lack the ability to replicate telomere
ends completely, telomere length homeostasis is crucial
to avoid premature cellular senescence and age-related
disease [2]. Telomere length homeostasis is mediated by
telomerase, a cellular telomere-specific reverse transcrip-
tase that uses an internal RNA moiety as a template for
the synthesis of telomere repeats. Mammalian telomeres
consist of tandem arrays of TTAGGG repeats, and the G-
rich strand extends beyond its complement to form a 3
0
overhang named the G-tail. The G-tail is a substrate of
telomerase, which elongates the 3
0 ends of chromosomes
by adding TTAGGG repeats. The complementary strand
is filled in by conventional DNA polymerases using
primase-derived short RNA oligonucleotides. The
TTAGGG repeats are recognized by subunits of a protein
complex called shelterin [4]. The shelterin complex,
which is specific for telomere ends, allows the cell to
distinguish telomeres from sites of DNA damage, thereby
protecting the telomeres from inappropriate processing
by DNA repair pathways [4].
In mammalian cells, the telomeres and subtelomeric
regions are organized into tightly packed nucleosomes
with several markers (e.g., trimethylation of histone H3
at lysine 9 [H3K9me3] and dimethylation or trimethyla-
tion of histone H4 at lysine 20), similar to constitutively
expressed heterochromatin [5]. Another characteristic
heterochromatic mark at mammalian telomeres consists
of subtelomeric cytosine DNA methylation within CpG
dinucleotides. These modifications may contribute to a
heterochromatin-like conformation and the observed
telomere position effect, which manifests as an ability to
silence the transcription of experimentally inserted
subtelomeric reporter genes [6-8].
Major recent advances
The heavily methylated state of subtelomeric regions, the
gene-less nature of telomeres, and the observed telomere
position effect led to the notion that telomeres are
transcriptionally silent [5-8]. This hypothesis was
recently challenged when several groups independently
demonstrated that subtelomeric and telomeric regions,
although devoid of genes, have the potential to be
transcribed into telomeric repeat-containing RNA
(TERRA) [9,10]. TERRA molecules have been identified
in human, mouse, fish, and recently baker’sy e a s t ,
indicating that TERRAs are conserved among eukaryotes.
TERRA transcripts are synthesized from the C-rich strand
and polyadenylated, and their synthesis is a-amanitin-
sensitive, suggesting that they are transcripts of RNA
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role for RNA Pol II in TERRA transcription derives from
the observation that RNA Pol II is enriched at telomeres
and associates with the telomeric DNA repeat-binding
protein TRF1. TERRA transcripts can be found through-
out the different stages of the cell cycle, and their levels
are affected by several factors that include telomere
length, tumor stage, cellular stress, developmental stage,
and telomeric chromatin structure. TERRA most likely
regulates telomere length directly since longer telomeres
produce more TERRA molecules and thereby create a
negative feedback by blocking telomere access to
telomerase [10]. However, it is largely unclear how the
expression of TERRA and the amount of TERRA
transcripts are regulated in the cell.
Insights into the possible regulation of TERRA synthesis
came from experiments demonstrating that TERRA
synthesis is upregulated by the mixed lineage leukemia
(MLL) protein, which is the mammalian homologue of
the Drosophila melanogaster trithorax protein, and p53
after the induction of telomere uncapping [12]. MLL is
cleaved into two fragments by taspase 1: the N-terminal
fragment associates the MLL complex to chromosomal
sites, whereas the C-terminal fragment contains a SET
(Suvar3-9, Enhancer-of-zeste, Trithorax) domain that
manifests H3/K4 histone methytransferase (HMT) activ-
ity. Besides its established role as an HMT and general
transcriptional regulator, MLL binds to telomeres. The
binding of MLL to telomeres has been shown to affect
telomere epigenetic status by methylating telomeric
H3K4 [12]. MLL also interacts with p53 to increase
TERRA synthesis in response to progressive telomere
uncapping [12]. Therefore, MLL-dependent TERRA
synthesis seems to represent a cellular response to
telomere uncapping, thereby preventing DNA damage
responses and the induction of cellular senescence.
Besides MLL, other proteins have been suggested to play
a role in regulating TERRA levels either directly or
indirectly [9,10]. For instance, downregulating the
cellular abundance of TRF1 has been shown to decrease
the cellular abundance of TERRA without affecting the
binding of RNA Pol II to telomeres [9]. Furthermore,
TERRA levels are increased in cells that are deficient for
certain HMTs, whereas TERRA levels are decreased in
cells lacking DNA methyl transferase (DNMT) proteins
or Dicer [10]. A role for these proteins in regulating
TERRA levels suggests that the heterochromatic state of
telomeric regions is important for the regulation of
TERRA synthesis.
In addition, several factors (UPF1, EST1A/SMG6, and
SMG1) of the mammalian-cell nonsense-mediated
mRNA decay (NMD) machinery are enriched at telo-
meres and negatively regulate TERRA association with
telomeric chromatin [9,13], suggesting a link between
TERRA, NMD factors, and telomere stability. Consistent
with a role for these NMD factors in telomerase
regulation, depletion of any one of these factors from
cells not only increases TERRA binding to telomeres but
also results in telomere damage and telomere loss [9].
A first clue to how TERRA transcripts might regulate
telomerase function came from experiments demonstrat-
ing that TERRA-mimetic oligonucleotides are able to
inhibit human telomerase in vitro [10]. This result
suggests that TERRA might directly inhibit telomerase
function by duplexing with the RNA moiety of the
telomerase.
The finding that TERRA is also present in the genetically
tractable Saccharomyces cerevisiae was instrumental to
further dissecting the processes that regulate TERRA
synthesis and TERRA cellular abundance [11]. Using
yeast, Lingner and colleagues [11] demonstrated that, in
rat1-1 mutant cells, which are deficient in the Rat1p 5
0-to-
3
0 exoribonuclease, much higher levels of TERRA could
be detected. This result indicates that Rat1p, which
functions in the decay of normal mRNAs and NMD
targets, degrades TERRA RNAs [11]. The association of
Rat1p with telomeres suggests that Rat1p might directly
degrade TERRA RNAs and provides the first evidence for
a role of RNA degradation in the regulation of the TERRA
transcriptome.
Like mammalian TERRAs, yeast TERRAs are transcribed
by RNA Pol II since they (a) fail to accumulate in rat1-1
mutant cells in which RNA Pol II has been co-inactivated
[11] and (b) are polyadenylated by the poly(A) poly-
merase Pap1p [11]. Since Pap1p adds poly(A) tails to
pre-mRNAs during the process of mRNA biogenesis, a
possible role during TERRA biogenesis for the same
endonucleolytic cleavage factors that generate substrates
for poly(A) addition during mRNA biogenesis was
tested. Interestingly, TERRA levels were indeed decreased
in rat1-1 cells harboring co-inactivated subunits of the
endonucleolytic cleavage factor CF1A, demonstrating the
importance of this factor in TERRA biogenesis [11].
These results suggest that TERRA processing involves the
Pap1p-mediated addition of poly(A) to TERRA 3
0 ends
that are generated by the same activities that generate
pre-mRNA 3
0 ends. Alternatively, the 5
0 ends of TERRA
that are generated by these activities could be degraded
by the 5
0-to-3
0 exonucleolytic activity of Rat1p [11].
Together, these results suggest an intimate interplay
between mRNA-processing pathways and TERRA turn-
over. Further support for the regulation of telomerase
Page 2 of 5
(page number not for citation purposes)
F1000 Biology Reports 2009, 1:90 http://F1000.com/Reports/Biology/content/1/90function by Rat1p and TERRA comes from the observa-
tion that rat1-1 mutant cells have short telomeres. TERRA
seems to inhibit telomerase activity directly since
telomeres were shown to shorten at the same rate in
telomerase-deficient cells that did or did not express
Rat1p.
How could TERRA regulate telomerase activity? Two
scenarios are conceivable. In one, TERRA could duplex
with the RNA moiety of telomerase and directly inhibit
telomerase activity. In the other, TERRA could associate
with telomeric DNA repeats and block telomerase access
to the telomeres. Support for the first mechanism comes
from experiments described above demonstrating that
TERRA-mimetic oligonucleotides inhibit telomerase
activity [10]. Support for the second scenario comes
from the finding that overexpressing ribonuclease H in
rat1-1 cells results in telomere lengthening. This observa-
tion suggests that telomerase function in rat1-1 cells is
inhibited by RNA/DNA hybrids formed between TERRA
and telomeric DNA [11]. However, inhibition was less
pronounced in cells with endogenous levels of ribonu-
clease H or in wild-type cells that overexpress ribonu-
clease H [11]. In theory, both mechanisms could regulate
telomerase activity at telomeric DNA ends, and future
experiments will undoubtedly address existing
uncertainties.
Together, these observations are of medical relevance
because abnormal levels of TERRA and the resulting
abnormal telomeric phenotypes are likely to affect
processes such as hematopoesis, embryonic develop-
ment, and stem cell biology. Indeed, increased TERRA
levels have already been associated with human disease
[14]. As a case in point, mutations within the DNA
methyltransferase 3b (DNMT3b) gene cause hypomethy-
lation of satellite and non-satellite repeat regions,
including subtelomeric regions, which leads to an
autosomal-recessive disease called ICF (immunodefi-
ciency, centromeric region instability, facial abnormal-
ities) syndrome [15]. In cells from ICF patients,
hypomethylation of subtelomeric regions was recently
associated with increased levels of TERRA synthesis and
accelerated telomere shortening [14]. These findings
provide a first mechanistic explanation for the observed
telomeric phenotype in ICF patients. However, these
observations are in contrast to the finding that TERRA
levels are decreased in cells deficient for DNMT1,
DNMT3a, and DNMT3b [10]. The use of different cell
lines (mouse embryonic stem cells versus somatic cells
from ICF patients) might account for the discrepancy.
Further support for TERRA RNA regulating telomerase
activity comes from the observation that tumor-derived
cell lines that rely on telomerase to maintain telomeres
manifest a decreased level of TERRA RNA when
compared with tumor-derived cells using the ALT
(alternative lengthening of telomeres) mechanism [16].
This decrease correlates mainly with increased cytosine
DNA methylation at positions that reside adjacent to
telomeres. Therefore, telomerase activity seemed to be
tightly linked to subtelomeric DNA methylation, TERRA
levels, and a telomeric heterochromatin state that
represses telomeric transcription.
Future directions
An important issue that has yet to be addressed is how
TERRA is specifically recruited to the telomeric regions.
One attractive scenario is that TERRA-specific binding
proteins assist in tethering TERRA RNA to telomeric
DNA. Good candidates would be telomere-associated
proteins that manifest RNA- or DNA-binding activity or
both, including the shelterin components TRF1 and
TRF2 [17]. Indeed, TERRA is recruited to the telomere via
direct interactions with TRF1 and TRF2. TERRA also
mediates interactions between TRF2 and the ORC1
subunit of the origin recognition complex (ORC),
thereby promoting the recruitment of ORC to telomeres.
This association was demonstrated to be important for
the enrichment of H3K9me3 and for HP1-mediated
heterochromatin formation at telomeres [17]. Therefore,
the TRF2-TERRA-ORC1 interactions seem to be critical
for telomere structural stability and heterochromatin
formation [10,17].
Defining possible roles for other TERRA-regulating
proteins such as UPF1, SMG1, or MLL will lead to a
deeper understanding of the function of TERRA in
telomere biology and the mechanism of TERRA biogen-
esis. Furthermore, the mode of TERRA-mediated regula-
tion of telomerase function – either via RNA/RNA hybrid
formation between TERRA and the telomerase RNA
moiety or via blocking telomerase access to the telomeric
repeat region – remains to be elucidated. Since certain
NMD factors, including UPF1, are able to promote
TERRA dissociation from telomeres, UPF1, which is an
RNA and DNA helicase, would be an attractive candidate
to regulate RNA/DNA hybrid formation. This would
directly link NMD factors, TERRA expression, and
telomere length homeostastis.
The identification of TERRA promoter regions and
transcription start sites will increase our understanding
of TERRA biogenesis. This information will help us to
understand whether TERRA RNA is required for the
heterochromatinization of eukaryotic telomeres, similar
to what has been observed for X-chromosome inactiva-
tion in females via Xist RNA (X inactive-specific
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patho-physiological perspective, unravelling the role of
TERRA at telomeres will enhance our insight into
processes such as aging and cancer.
The elucidation of the structures of TERRA RNAs will
provide an additional understanding of the functions of
these non-coding RNAs. In a recent report, Randall and
Griffith [19] proposed a beads-on-a-string model for
long telomeric RNA folding, in which individual
(UUAGGG)4 units form quadruplex beads that are
connected by UUA linkers. Future studies will undoubt-
edly examine the structure of RNA-protein complexes
formed with the G-rich telomeric RNA.
It will be interesting to see whether further insights into
TERRA regulation will advance our understanding of
mechanisms that are central to stem cell biology. Along
this line, promoting TERRA synthesis might be advanta-
geous during stem cell expansion protocols. Lastly, since
telomerase is viewed as an almost universal marker for
human cancer, the inhibition of telomerase is an
attractive strategy for new cancer therapeutics. The
finding that TERRA-mimetic oligonucleotides regulate
telomerase activity will hopefully soon translate basic
research on TERRA function and regulation into new
telomerase-directed therapeutic approaches in cancer.
Notably, TERRA RNA is present in cells without
detectable telomerase activity [12,16]. Therefore, it will
be important to elucidate roles for TERRA RNA other
than in regulating telomerase activity (e.g., in cells that
are devoid of any telomere maintenance mechanism).
For one, TERRA has been proposed to play an important
role in heterochromatin formation and maintenance
[17]. Additionally, TERRA could help to regulate
telomere DNA replication via its interaction with ORC.
Furthermore, although TERRA localizes mainly to
telomeric repeats, it is possible that TERRA binds to
other chromosomal locations to exert yet-undiscovered
functions.
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